International Health Expert Leads Cedars-Sinai Delegation at Arab Health 2022
Heitham Hassoun, MD, to Open Cedars-Sinai’s First Arab Health Booth and Highlight the Health System’s Partnerships in the Middle East and Beyond
Cedars-Sinai will debut its first booth appearance at Arab Health 2022, from Jan. 24-27 in Dubai, United Arab Emirates. The Cedars-Sinai International team will be showcasing current and upcoming regional partnerships at the exhibition in Hall 6, Booth C12.
While this is Cedars-Sinai's debut at Arab Health, Heitham Hassoun, MD, vice president and medical director of Cedars-Sinai International, is a veteran of the event and a prominent expert on international health.
“Cedars-Sinai has strong connections in the UAE and throughout the region, and we’re excited for the opportunity to showcase and expand those relationships at Arab Health,” he said.
Hassoun will be attending the conference and will be available for interviews about:
· Cedars-Sinai’s leading-edge, patient-focused expertise in specialties including orthopaedics, heart, cancer and the neurosciences.
· Cedars-Sinai International’s focus on supporting patients and providers, both at Cedars-Sinai’s Los Angeles-area facilities and around the world.
· Cedars-Sinai’s partnerships in the Middle East, including a collaboration with Elegancia Healthcare on The View hospital, a world-class healthcare facility set to open in Doha, Qatar, in August 2022. The 242-bed hospital will be the first in Qatar to offer patients a private healthcare option.
“Cedars-Sinai International is the global extension of Cedars-Sinai’s mission, vision and values,” Hassoun said. “To that end, our focus is on bringing world-class patient care wherever we go.”
Cedars-Sinai is ranked nationally in 11 specialties and is on the "Honor Roll" in U.S. News & World Report "Best Hospitals 2021-22.”
Since its beginning in 1902, Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards in quality and innovation in patient care, research, teaching and community service.
Today, Cedars-Sinai is widely known for its national leadership in transforming healthcare for the benefit of patients.
Cedars-Sinai is one of the largest nonprofit academic medical centers in the U.S. with 886 licensed beds, 2,100 physicians, 3,000 nurses and thousands of other healthcare professionals and staff. Clinical programs range from primary care for preventing, diagnosing and treating common conditions to specialized treatments for rare, complex and advanced illnesses. In addition, Cedars-Sinai serves the community through its Medical Network, which includes the highly rated Cedars-Sinai Medical Group and Cedars-Sinai Health Associates.
Cedars-Sinai has consistently been named one of America's Best Hospitals by U.S. News & World Report, has received the National Research Corporation's Consumer Choice Award 20 years in a row for providing the highest quality medical care in Los Angeles, and has the longest running Magnet designation for nursing excellence in California.
Cedars-Sinai is a leader in the clinical care and research of heart disease, cancer and brain disorders, among other areas. Pioneering research achievements include using cardiac stem cells to repair damaged hearts, developing minimally invasive surgical techniques and discovering new types of drugs to target cancer more precisely.
Cedars-Sinai also impacts the future of healthcare through education programs that encompass everything from highly competitive medical residency and fellowship programs to a biomedical science and translational medicine PhD program, advanced training for nurses and educational opportunities for allied health professionals. Most notably, Cedars-Sinai demonstrates a longstanding commitment to strengthening the Los Angeles community through wide-ranging programs that improve the health of its most vulnerable residents.
Read more in the Cedars-Sinai Blog: Global Perspectives – Healthcare Beyond Borders